A kind of preparation method of antitumor hydrogel
A hydrogel and anti-tumor technology, applied in the field of biomedical materials, can solve the problems of clinical application limitations, shortened release cycle, and excessive release, etc., to achieve efficient control of drug release speed, enhance anti-tumor effect, and prolong release time Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Mix the graphene oxide solution loaded with doxorubicin (the content of doxorubicin is 4mg / ml, the concentration of graphene oxide is 2mg / ml) and 7.5% (W / V) sericin solution in the dark Obtain mixed solution, the volume ratio of the two is 1:5;
[0021] Mix the above mixture with 10% (W / V) gelatin solution, the volume ratio of the two is 1.5:1, then add glutaraldehyde, add 0.05g of 25% (W / V) glutarin for every 1g of sericin The aldehyde was reacted at 40° C. for 20 minutes to obtain a graphene oxide-doxorubicin-sericin-gelatin hydrogel, which is the anti-tumor hydrogel of the present invention.
Embodiment 2
[0023] A solution of graphene oxide loaded with doxorubicin (the content of doxorubicin is 2.5 mg / ml, and the concentration of graphene oxide is 1.5 mg / ml) and 0.5% (W / V) sericin solution were prepared under dark conditions. Mix evenly to obtain a mixed solution, and the volume ratio of the two is 1:3.
[0024] Mix the above mixture with 5% (W / V) gelatin solution, the volume ratio of the two is 1:1, then add glutaraldehyde, add 0.15g of 25% (W / V) glutaraldehyde per 1g of sericin Aldehydes were reacted at 30° C. for 4 hours to obtain graphene oxide-doxorubicin-sericin-gelatin hydrogel, which is the anti-tumor hydrogel of the present invention.
Embodiment 3
[0026] A solution of doxorubicin-loaded graphene oxide (the content of doxorubicin is 1 mg / ml and the concentration of graphene oxide is 1 mg / ml) was mixed with a 10% (W / V) sericin solution in the dark Obtain the mixed liquid evenly, and the volume ratio of the two is 1:2.
[0027] Mix the above mixture with 7.5% (W / V) gelatin solution, the volume ratio of the two is 0.5:1, then add glutaraldehyde, add 0.25g of 25% (W / V) glutaraldehyde per 1g of sericin The dialdehyde was reacted at 20° C. for 12 hours to obtain graphene oxide-doxorubicin-sericin-gelatin hydrogel, which is the anti-tumor hydrogel of the present invention.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


